Email Updates

You are here

Home

24 MARCH 2023 VOLUME 25 ISSUE 12

Media Coverage

  • Tennessee’s Rejection of $8.8 Million in Federal Funding Alarms HIV Prevention Groups

    After offering free HIV testing at a drive-through event last year, staff members at Nashville CARES, a nonprofit sexual health clinic, made an alarming discovery: a cluster of positive tests from a single neighborhood. “There was one person who had unknowingly passed it to multiple partners, and we were able to intervene quickly before it became a full-blown outbreak,” said Lisa Binkley, who leads the clinic’s HIV prevention team.

    March 24, 2023
    General
    New York Times

  • AVAC Condemnation of Uganda’s Anti-Homosexuality Bill 2023

    This week, Ugandan Parliamant took steps toward implementing an anti-gay policy change that would further criminalize and endanger the lives of LGBTQIA+ people. AVAC condemns the proposed legislation and stands in solidarity with the LGBTQIA+ community in Uganda who face threats to their lives, draconian prison terms, and even the prospect of death sentences if this legislation goes forward.

    March 24, 2023
    General
    AVAC

  • STI PEP Seeks to Mirror HIV Success

    The introduction of highly active antiretroviral therapies in the late 1980s and pre-exposure prophylaxis (PrEP) in 2012 changed the trajectory of HIV infection, not only enabling people to live longer, healthier lives, but also lowering transmission rates. As a result, new HIV infections declined 8 percent from 2015 to 2019 in the United States, according to the CDC.

    March 23, 2023
    General
    Infectious Disease Special Edition

  • Home-Based HPV Cervical Cancer Screening 'Cost-Effective'

    For women who are overdue for cervical cancer screening, mailing self-sampling kits for high-risk human papillomavirus (HPV) is a cost-effective means of increasing screening uptake, reveals an analysis of a large US trial. The finding comes from a randomized trial in almost 20,000 women, which compared women who received a mailed HPV testing kit with those who did not. The results show that mailing was most cost-effective in women aged 50-64 years and in those who were only recently overdue for cervical screening.

    March 22, 2023
    General
    Medscape

  • Mailing HPV Kits Effective for Increasing Cervical Cancer Screening Uptake

    Mailing HPV self-sampling kits to women who are overdue for cervical cancer screening was cost-effective in increasing screening uptake compared with usual care, according to an economic evaluation published in JAMA Network Open.“Home-based HPV-only screening is feasible because, unlike Papanicolaou tests, both clinicians and individuals can collect vaginal HPV samples.

    March 22, 2023
    General
    Healio

  • Uganda Passes a Law Making It a Crime To Identify as LGBTQ

    Uganda's parliament passed a law on Tuesday making it a crime to identify as LGBTQ, handing authorities broad powers to target gay Ugandans who already face legal discrimination and mob violence. More than 30 African countries, including Uganda, already ban same-sex relations. The new law appears to be the first to outlaw merely identifying as lesbian, gay, bisexual, transgender and queer (LGBTQ), according to rights group Human Rights Watch.

    March 22, 2023
    General
    Reuters

  • Strong Support Systems Tied to PrEP Adherence Among Adolescent Girls and Young Women in South Africa

    A qualitative study published in PLOS Global Public Health explored how disclosure of PrEP use was related to adherence among adolescent girls and young women in South Africa. Those who received positive reactions generally had high adherence and disclosed more readily to more people. Those with low adherence were more fearful to disclose and received more neutral or negative reactions.

    March 21, 2023
    PrEP
    aidsmap

  • Advocates Try to Halt a Wacky, Dangerous Book from an HIV Denialist

    We all know the saying about freedom of speech. It doesn’t mean you have the right to yell “fire!” in a crowded movie theater. That kind of speech can risk lives. But what if the theater is already burning on all sides, and someone tries to convince people not to find a safe exit, that the approaching flames can’t possibly harm them, or that the fire itself is a myth or a conspiracy?

    March 20, 2023
    POZ Magazine

  • Black Gay Men and Trans Women Are Well Protected by Injectable PrEP

    Long-acting injectable cabotegravir (Apretude) offered greater protection than daily pre-exposure prophylaxis (PrEP) pills for Black gay and bisexual cisgender men and transgender women, but Black people still had higher HIV incidence rates compared with their white peers regardless of which type of PrEP they used, researchers reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI).

    March 20, 2023
    PrEP
    POZ Magazine

  • Dealing with Racial Power Dynamics in HIV Care: Question Everything

    Black and other global majority people are often forced to deal with white supremacy, even in medical spaces, where―according to the Association of American Medical Colleges―in 2021, 63.9 percent of all active physicians in the United States identified as white. Though Black people do not cause racism, they are often asked to resolve it, while also negotiating tone, policy, structural barriers, and seeking care.

    March 20, 2023
    Treatment
    TheBody

  • Incidence of HIV-Related Kaposi’s Sarcoma Not Improving in East Africa

    People in East Africa with HIV-related Kaposi’s sarcoma often have advanced disease and a poor survival outlook — and the situation has not improved in the last 5 years, a study found. People with HIV are at increased risk for Kaposi’s sarcoma (KS), a cancer of the cells lining blood or lymphatic vessels that is linked to herpesvirus infection, and incidence rates are higher in some parts of sub-Saharan Africa.

    March 20, 2023
    Treatment
    Healio

  • FDA Grants Clearance for Fast, Point-of-Care STI Test for Women

    The FDA has granted 501(k) clearance and a Clinical Laboratory Improvement Amendments waiver for a polymerase chain reaction diagnostic test to detect sexually transmitted infections in women, according to a press release. Visby Medical’s second-generation sexual health test is an instrument-free platform using polymerase chain reaction technology to test for chlamydia, gonorrhoeae and trichomonas from a single sample collected by the patient.

    March 20, 2023
    General
    Healio

  • Can HIV Self-Test Help India End AIDS?

    Testing is paramount to identify HIV cases, and making self-testing a national policy can certainly pave the way for ending AIDS in India, health experts contended on Sunday. Globally almost half of the countries (98) have included HIV self-testing policies, and one-fourth nations globally (52) are routinely implementing it. However, India is among the countries that have not yet developed a national policy on HIV self-testing.

    March 19, 2023
    General
    TIMES NOW

  • HIV Drug PrEP’s Popularity Soars – But Only Among White Men

    PrEP has become extremely popular in the US with gay and bisexual men – but only among those who are white, according to new findings. Pre-exposure prophylaxis (PrEP) – the oral medication used to prevent HIV infections – has been hailed as groundbreaking all over the world. However, despite being readily available in the US for a decade, new HIV infections have only seen a steady decrease amongst gay and bisexual white men.

    March 19, 2023
    PrEP
    PinkNews

  • A Look at PEPFAR’s Legacy: 20 Years of Fighting AIDS

    NPR's Pien Huang speaks with epidemiologist Dr. Helene Gayle about the 20th anniversary of PEPFAR, the President's Emergency Plan for AIDS Relief.

    March 18, 2023
    General
    NPR

  • Hopeful HIV and Hepatitis News in Biden’s Proposed 2024 Budget

    HIV and hepatitis advocates see promising signs in President Joe Biden’s proposed budget for fiscal year 2024, which was released last week. Of note, Biden seeks to increase efforts to end HIV by $313 million and to launch programs to eliminate hepatitis C and increase access to pre-exposure prophylaxis, or PrEP, the daily pills and long-acting injections that prevent HIV.

    March 17, 2023
    General
    POZ Magazine

  • Mpox Going Undiagnosed Among Homeless People

    The homeless, particularly those staying in encampments, may have undetected mpox infections, according to a CDC report. The report highlighted the need for dedicated outreach to people experiencing unstable housing during public health emergencies, as well as the need for tailored outreach strategies that ensure interventions, such as prevention messaging and vaccination, reach individuals experiencing homelessness, the investigators stated.

    March 17, 2023
    General
    Infectious Disease Special Edition

  • How Are People Cured of HIV? Here’s Everything You Need To Know

    In the past 20 years, a handful of people have been cured of human immunodeficiency virus (HIV), the virus that causes AIDS, through intensive medical procedures. Several more people have received the treatment and also appear to be HIV-free, but it's too soon to definitively declare these patients cured. For now, they're described as being in long-term remission, and their cases are considered "possible" cures. All these patients received stem cell transplants, with cells collected either from adult bone marrow or from umbilical cord blood.

    March 17, 2023
    Cure
    Live Science

  • Interest Grows in Long-Acting Injectables for HIV Treatment

    With recent innovations in the development of antiretroviral therapy (ART), there is growing interest in the use of long-acting injectable (LAI) therapy. Patients may benefit from the use of an injectable regimen to avoid pill fatigue and reduce confidentiality concerns, and it may also promote therapy adherence.

    March 17, 2023
    Treatment
    Pharmacy Times

Published Research

Announcements